Results 251 to 260 of about 605,792 (294)

Somatostatin Analogs Inhibit Neonatal Retinal Neovascularization

Experimental Eye Research, 2002
The goal of this study was to determine the effect of two somatostatin analogs, Woc4D and octreotide, on oxygen induced retinopathy in the mouse. Oxygen induced retinopathy was produced in C57BL6 mice. Octreotide and Woc4D were administered from post-natal day 12-16.
Rosemary D, Higgins, Yun, Yan, Bruce K, Schrier   +2 more
openaire   +2 more sources

Octreotide: A Long-Acting Somatostatin Analog

The American Journal of the Medical Sciences, 1990
One of the exciting recent developments in endocrinology research has been the introduction of the somatostatin analog, octreotide into clinical practice. Octreotide provides a new therapeutic tool for diseases in which somatostatin or somatostatin-like products are secreted abnormally.
Nancy Brown, Philip E. Johnston, Patricia Arns, Renata Bluhm, Robert A. Branch   +4 more
openaire   +2 more sources

Targeted Radiotherapy with Radiolabeled Somatostatin Analogs

Endocrinology and Metabolism Clinics of North America, 2011
Targeted radiopeptide therapy with (90)Yttrium- or (177)Lutetium-labeled somatostatin analogs has been proven to improve significantly quality of life and survival in patients suffering from metastatic or unresectable neuroendocrine tumors (NETs). Roughly 25% of patients achieve partial remission; progression-free survival is estimated to be 30 to 40 ...
Nicolas, Guillaume, Giovacchini, Giampiero, Müller-Brand, Jan, Forrer, Flavio   +3 more
openaire   +2 more sources

Antiproliferative Effect of Somatostatin and Analogs

Chemotherapy, 2001
Over the past decade, antiproliferative effects of somatostatin and analogs have been reported in many somatostatin receptor-positive normal and tumor cell types. Regarding the molecular mechanisms involved, somatostatin or analogs mediate their action through both indirect and direct effects.
C, Bousquet, E, Puente, L, Buscail, N, Vaysse, C, Susini   +4 more
openaire   +2 more sources

Somatostatin analog treatment of pancreatic fistulas

International journal of pancreatology, 1993
In order to hasten healing of pancreatic fistulas, we have treated 11 men and one woman with octreotide, a long-lasting somatostatin analog. This agent was administered subcutaneously in doses of 0.05-0.20 mg, two to three times per day. Fistulas were secondary to pancreatic biopsy (1), pancreatic abscess drainage (2), operative injury (3), and blunt ...
S M, Barnes, B G, Kontny, R A, Prinz
openaire   +2 more sources

Radiolabeled somatostatin analogs in prostate cancer

Nuclear Medicine and Biology, 1997
Vapreotide (RC-160), a somatostatin analog, was labeled with 99mTC by a direct method and also by using CPTA [1,4,8,11-tetraazacyclotetradecane] as a bifunctional chelating agent. The labeled compounds were evaluated in nude mice bearing experimental human prostate cancers. In these studies, 111In-DTPA-D-Phe-Octreotide (111In-DTPA-octreotide) served as
M L, Thakur, H, Kolan, J, Li, R, Wiaderkiewicz, V R, Pallela, R, Duggaraju, A V, Schally   +6 more
openaire   +2 more sources

Two Types of Somatostatin Receptors Differentiated by Cyclic Somatostatin Analogs

Science, 1985
Somatostatin receptors in rat brain, pituitary, and pancreas were labeled with two radioiodinated analogs of somatostatins 14 and 28. Two cyclic analogs of somatostatin, SMS201-995 and cyclo(Ala-Cys-Phe-D-Trp-Lys-Thr-Cys), showed biphasic displacement of binding to somatostatin receptors by these radioligands.
V T, Tran, M F, Beal, J B, Martin
openaire   +2 more sources

Intrathecal somatostatin, somatostatin analogs, substance P analog and dynorphin A cause comparable neurotoxicity in rats

Neuroscience, 1990
Rats chronically implanted with intrathecal catheters received intrathecal injections (10 microliters followed by 10 microliters saline flush) of either saline (n = 5), somatostatin (100 micrograms, n = 10), the somatostatin analog BIM 23003 (100 micrograms, n = 5), the somatostatin analog SMS 201-995 (100 micrograms, n = 5), the substance P analog [D ...
D M, Gaumann, T S, Grabow, T L, Yaksh, S J, Casey, M, Rodriguez   +4 more
openaire   +2 more sources

[Somatostatin analogs in oncology].

Bulletin du cancer, 1991
Somatostatin octapeptide analogues have a longer half-life and are more potent than natural somatostatin (SS-14). Somatostatin analogues are presently approved for the treatment of gastrointestinal (GI) endocrine cancers such as carcinoids, vipomas and glucagonomas.
F, Thomas, H, Parmar, G, Prevost, J M, Kuhn, J L, Bejot, J P, Moreau, A, Bogden   +6 more
openaire   +1 more source

Octreotide: A Synthetic Analog of Somatostatin

Drug Intelligence & Clinical Pharmacy, 1988
Octreotide is an investigational synthetic peptide exhibiting actions similar to those of endogenous somatostatin. It has a longer half-life than the native hormone and can be administered by subcutaneous injection. Octreotide inhibits the secretion of growth hormone and numerous regulatory peptides of the gastroenteropancreatic system.
openaire   +2 more sources